Replies to post #28268 on Relief Therapeutics Holding AG (RLFTF)

[randychub]

Not true. Mostly likely we will need both. If we are able to make enough product we will easily be them on price MABS are very expensive

[aGuyUS]

Doesn't dampen the market for inhaled version..

Our market for inhale use is the world with a treatment like. 1/3 te cost of Regeneron REGN-COV2